Treatment of recalcitrant orbital inflammatory syndrome with plasmapheresis therapy.
eye
haematology (incl blood transfusion)
Journal
BMJ case reports
ISSN: 1757-790X
Titre abrégé: BMJ Case Rep
Pays: England
ID NLM: 101526291
Informations de publication
Date de publication:
08 Jan 2020
08 Jan 2020
Historique:
entrez:
11
1
2020
pubmed:
11
1
2020
medline:
20
8
2020
Statut:
epublish
Résumé
Refractory idiopathic orbital inflammation (IOI) represents a management challenge due to its significant proportion of treatment failures. Currently, there are no established guidelines for recalcitrant IOI and majority of immunosuppressive agents have resulted in variable outcomes. Advancements of plasmapheresis therapy can play a significant role in ophthalmological diseases. This treatment has shown to produce a satisfactory therapeutic response in immune-mediated neurological conditions. In this case report, we share our successful experience with the use of plasmapheresis therapy in a patient with recalcitrant IOI.
Identifiants
pubmed: 31919064
pii: 13/1/e232379
doi: 10.1136/bcr-2019-232379
pmc: PMC6954793
pii:
doi:
Substances chimiques
Antineoplastic Agents, Immunological
0
Rituximab
4F4X42SYQ6
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© BMJ Publishing Group Limited 2020. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Ophthalmic Plast Reconstr Surg. 2006 Mar-Apr;22(2):79-86
pubmed: 16550048
Eye (Lond). 2006 Oct;20(10):1196-206
pubmed: 17019419
Clin Rheumatol. 2009 Feb;28(2):225-6
pubmed: 19015801
Int Ophthalmol. 2018 Aug;38(4):1485-1495
pubmed: 28634929
Neurology. 2011 Jun 7;76(23):2017-23
pubmed: 21562253
Am J Ophthalmol. 2005 Nov;140(5):916-8
pubmed: 16310473
Am J Ophthalmol. 2004 Dec;138(6):1041-3
pubmed: 15629299
Muscle Nerve. 2013 Apr;47(4):510-4
pubmed: 23322564
Neurologist. 2007 Jan;13(1):2-11
pubmed: 17215722
Arch Ophthalmol. 2003 Apr;121(4):491-9
pubmed: 12695246
Ocul Immunol Inflamm. 2015 Apr;23(2):176-9
pubmed: 24354478
Am J Ophthalmol. 2004 Dec;138(6):925-30
pubmed: 15629282
Curr Rheumatol Rep. 2010 Dec;12(6):443-7
pubmed: 20803107
J Clin Apher. 2011 Dec;26(6):356-61
pubmed: 21898575